Navigation Links
Novel technology could produce biofuel for around €0.50 a liter ($2.49 a gallon)
Date:1/29/2009

A novel technology for synthesising chemicals from plant material could produce liquid fuel for just over 0.50 a litre, say German scientists. But only if the infrastructure is set up in the right way, states the research published in this month's issue of Biofuels, Bioproducts & Biorefining.

Developed by scientists at the Karlsruhe Institute of Technology (KIT), this novel technology is known as bioliq, and is able to produce a range of different types of liquid fuel and chemicals from plant material such as wood and straw.

Bioliq involves first heating the plant material in the absence of air to around 500C, a process known as pyrolysis. This produces a thick oily liquid containing solid particles of coke termed biosyncrude.

The biosyncrude is then vaporised by exposing it to a stream of oxygen gas, before being heated at high pressures to a temperature of around 1400C. Known as gasification, this process transforms the liquid biosyncrude into a mixture of carbon monoxide and hydrogen termed syngas.

After any impurities are removed from this syngas, it can be catalytically converted into a range of different chemicals and fuels, including methanol, hydrogen and a synthetic version of diesel. This stage of the technology is fairly well developed, as syngas derived from coal and natural gas is already used to produce liquid fuels on a commercial scale in South Africa.

Bioliq is now taking its first steps towards commercialisation. In conjunction with the German process engineering company Lurgi, KIT is starting to construct a pilot plant based on the bioliq technology, which should be fully completed in 2012. Providing the technology works at this scale, the question then will be how best to implement bioliq at a larger scale, so that it can effectively compete with fossil fuels.

To try to come up with an answer, a team of KIT scientists led by Nicolaus Dahmen has used a simple economic model to calculate the cost of producing fuel at a bioliq plant with an annual production capacity of around 1 million tonnes. This is around a tenth of the size of a modern oil refinery, but is a similar size to refineries that produce liquid fuel from oil and gas.

Dahmen and his colleagues quickly realised that incorporating both the pyrolysis and gasification steps at this central plant wouldn't work, because of the problems and expense involved in transporting sufficient quantities of bulky straw and wood to the plant. They estimated that if sufficient plant material was transported on trucks, it would quickly bring the road network around the plant to a halt.

So they came up with an alternative set-up. "Biomass is pre-treated in around 50 regionally distributed pyrolysis plants to produce the biosyncrude," explains Dahmen. "This can then be transported economically over long distances to supply a central fuel production plant with a high capacity."

The advantage of this set-up is that it is much cheaper and more convenient to transport liquid biosyncrude than bulky wood and straw. This is especially the case if the biosyncrude is transported by rail, which is the most cost effective way to transport material over long distances.

So Dahmen and his colleagues produced an economic model based on this set-up, which suggests that the bioliq technology can potentially produce liquid fuels for 0.56𔂿.04 a litre. This would still make the fuel more expensive than conventional petrol or diesel, but this difference could be greatly reduced if different levels of tax were applied to the fuels.


'/>"/>

Contact: Jennifer Beal
wbnewseurope@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Studies point to novel target for treating arrhythmias
2. Novel technique changes lymph node biopsy, reduces radiation exposure
3. Novel technique changes lymph node biopsy, reduces radiaiton exposure
4. Salk researchers develop novel glioblastoma mouse model
5. Novel technique for fluorescence tomography of tumors in living animals
6. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
7. Stowers Institutes Workman Lab discovers novel histone demethylase protein complex
8. A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart
9. A novel target for therapeutics against Staph infection
10. Corn researchers discover novel gene shut-off mechanisms
11. 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
Breaking Biology Technology: